SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CTEC: Cholestech any other investors? -- Ignore unavailable to you. Want to Upgrade?

To: Phil Rogers who wrote (475)4/1/1998 7:25:00 PM
From: Duane L. Olson  Read Replies (1) | Respond to of 710
 
Phil, And assuming this CT approach to screening were to become widespread...would it not identify a LOT of folks who would need fairly continuous tesing and monitoring of cholesterol levels as part of the remedial program? Appreciate any professional enlightenment you can add..
Duane (Heavily committed to CTEC) :-)



To: Phil Rogers who wrote (475)4/2/1998 2:04:00 PM
From: Turs  Respond to of 710
 
Phil - I would tend to believe you. Everybody always seems to want to grab the headlines at these things and they usually exaggerate the magnitude of the "breakthrough" they have discovered.

In addition, everyone should note that IMAT is a $3 stock that has been around publicly for at least 20 years and has been losing money constantly. However, it would also be prudent to note that CTEC was a $3, money-losing stock at one time.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News